Ypsomed Holding AG logo

Ypsomed Holding AG (OWX)

Market Open
6 Aug, 17:31
XDUS XDUS
408. 40
-3.2
-0.7775%
- Market Cap
69.47 P/E Ratio
9.62% Div Yield
0 Volume
0 Eps
411.6
Previous Close
Add Transaction
Day Range
408.4 412.6
Year Range
291 447.5
Want to track OWX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

OWX trading today lower at €408.4, a decrease of -0.7775% from yesterday's close, completing a monthly decrease of -1.7797% or -€7.4. Over the past 12 months, OWX stock gained 16.3533%.
OWX pays dividends to its shareholders, with the most recent payment made on Jul 07, 2026. The next estimated payment will be in In 10 months on Jul 07, 2027 for a total of €4.4.
The last earnings report, released on May 19, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
Ypsomed Holding AG has completed 2 stock splits, with the recent split occurring on Jun 16, 2022.
The company's stock is traded on 7 different exchanges and in various currencies, with the primary listing on SIX (CHF).

OWX Chart

Ypsomed Holding AG (OWX) FAQ

What is the stock price today?

The current price is €408.40.

On which exchange is it traded?

Ypsomed Holding AG is listed on XDUS.

What is its stock symbol?

The ticker symbol is OWX.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 9.62%.

What is its market cap?

As of today, no market cap data is available.

Has Ypsomed Holding AG ever had a stock split?

Ypsomed Holding AG had 2 splits and the recent split was on Jun 16, 2022.

Ypsomed Holding AG Profile

Electronic Equipment, Instruments & Components Industry
Information Technology Sector
Simon Michel CEO
XDUS Exchange
CH0019396990 ISIN
CH Country
2,600 Employees
3 Jul 2026 Last Dividend
16 Jun 2022 Last Split
- IPO Date

Overview

Ypsomed Holding AG is a distinguished enterprise that focuses on the innovation, production, and distribution of injection and infusion solutions tailored for the pharmaceutical and biotechnology sectors. The organization is bifurcated into two primary divisions, namely Ypsomed Delivery Systems and Ypsomed Diabetes Care, catering to distinct facets of medical care and delivery mechanisms. With its foundations dating back to 1984, Ypsomed stands as a pioneering entity headquartered in Burgdorf, Switzerland. It maintains a robust operational footprint spreading across Switzerland, Europe, North America, and several other international territories. Ypsomed distinguishes itself in the market through strategic partnerships with pharmaceutical entities, complemented by its own expansive distribution network and collaboration with independent distributors.

Products and Services

  • Ypsomed Delivery Systems

    This segment of Ypsomed specializes in offering a wide array of injection systems which includes pen injectors, autoinjectors, and wearable injectors alongside intelligent device solutions. Under the YDS brand, Ypsomed provides pioneering solutions designed for ease of use, enhancing patient compliance, and ensuring accurate dosing. Their products cater to various medical needs, supporting the delivery of medications for chronic conditions with precision and reliability.

  • Ypsomed Diabetes Care

    Focused on the everyday needs of individuals managing diabetes, this division delivers a comprehensive suite of products. The mylife brand oversees the provision of insulin pumps and infusion sets designed for seamless insulin management. Additionally, it offers pen needles and blood glucose monitoring systems to ensure continuous and precise monitoring of blood glucose levels. Accessories and other daily diabetes management tools also form part of this segment's offerings, ensuring individuals living with diabetes have access to comprehensive care solutions.

  • Precision Turned Parts

    Ypsomed offers high-precision components that are integral to the medical and pharmaceutical devices they specialize in. This service underscores Ypsomed's commitment to quality and precision in every product and service offered, reflecting their expertise in creating components that meet the strictest standards required in medical device manufacturing.

  • Contract Manufacturing and Other Services

    In addition to its proprietary product lines, Ypsomed leverages its manufacturing expertise to offer contract manufacturing services. This includes the production of bespoke devices and components for pharmaceutical and biotechnology companies. By providing such services, Ypsomed supports the broader healthcare sector with its advanced manufacturing capabilities, facilitating the development and delivery of innovative medical solutions.

Contact Information

Address: Brunnmattstrasse 6
Phone: 41 34 424 41 11